2711 related articles for article (PubMed ID: 29588315)
1. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion.
Yalcinkaya M; Fotakis P; Liu W; Endo-Umeda K; Dou H; Abramowicz S; Xiao T; Libby P; Wang N; Tall AR; Westerterp M
Cardiovasc Res; 2023 May; 119(4):969-981. PubMed ID: 36537208
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.
Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450
[TBL] [Abstract][Full Text] [Related]
4. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis.
Tumurkhuu G; Dagvadorj J; Porritt RA; Crother TR; Shimada K; Tarling EJ; Erbay E; Arditi M; Chen S
Cell Metab; 2018 Sep; 28(3):432-448.e4. PubMed ID: 29937375
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice.
Westerterp M; Murphy AJ; Wang M; Pagler TA; Vengrenyuk Y; Kappus MS; Gorman DJ; Nagareddy PR; Zhu X; Abramowicz S; Parks JS; Welch C; Fisher EA; Wang N; Yvan-Charvet L; Tall AR
Circ Res; 2013 May; 112(11):1456-65. PubMed ID: 23572498
[TBL] [Abstract][Full Text] [Related]
7. Inflammasomes, neutrophil extracellular traps, and cholesterol.
Tall AR; Westerterp M
J Lipid Res; 2019 Apr; 60(4):721-727. PubMed ID: 30782961
[TBL] [Abstract][Full Text] [Related]
8. BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in
Yalcinkaya M; Liu W; Thomas LA; Olszewska M; Xiao T; Abramowicz S; Papapetrou EP; Westerterp M; Wang N; Tabas I; Tall AR
Circulation; 2023 Nov; 148(22):1764-1777. PubMed ID: 37781816
[TBL] [Abstract][Full Text] [Related]
9. Inflammasome Activation Aggravates Cutaneous Xanthomatosis and Atherosclerosis in ACAT1 (Acyl-CoA Cholesterol Acyltransferase 1) Deficiency in Bone Marrow.
Wakabayashi T; Takahashi M; Yamamuro D; Karasawa T; Takei A; Takei S; Yamazaki H; Nagashima S; Ebihara K; Takahashi M; Ishibashi S
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2576-2589. PubMed ID: 30354239
[TBL] [Abstract][Full Text] [Related]
10. Ogg1-Dependent DNA Repair Regulates NLRP3 Inflammasome and Prevents Atherosclerosis.
Tumurkhuu G; Shimada K; Dagvadorj J; Crother TR; Zhang W; Luthringer D; Gottlieb RA; Chen S; Arditi M
Circ Res; 2016 Sep; 119(6):e76-90. PubMed ID: 27384322
[TBL] [Abstract][Full Text] [Related]
11. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S
FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis.
Hettwer J; Hinterdobler J; Miritsch B; Deutsch MA; Li X; Mauersberger C; Moggio A; Braster Q; Gram H; Robertson AAB; Cooper MA; Groß O; Krane M; Weber C; Koenig W; Soehnlein O; Adamstein NH; Ridker P; Schunkert H; Libby P; Kessler T; Sager HB
Cardiovasc Res; 2022 Oct; 118(13):2778-2791. PubMed ID: 34718444
[TBL] [Abstract][Full Text] [Related]
13. Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner.
Jiang T; Ren K; Chen Q; Li H; Yao R; Hu H; Lv YC; Zhao GJ
Cell Physiol Biochem; 2017; 43(4):1703-1717. PubMed ID: 29045950
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
Duewell P; Kono H; Rayner KJ; Sirois CM; Vladimer G; Bauernfeind FG; Abela GS; Franchi L; Nuñez G; Schnurr M; Espevik T; Lien E; Fitzgerald KA; Rock KL; Moore KJ; Wright SD; Hornung V; Latz E
Nature; 2010 Apr; 464(7293):1357-61. PubMed ID: 20428172
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity.
Westerterp M; Gautier EL; Ganda A; Molusky MM; Wang W; Fotakis P; Wang N; Randolph GJ; D'Agati VD; Yvan-Charvet L; Tall AR
Cell Metab; 2017 Jun; 25(6):1294-1304.e6. PubMed ID: 28479366
[TBL] [Abstract][Full Text] [Related]
16. p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.
Rajamäki K; Mäyränpää MI; Risco A; Tuimala J; Nurmi K; Cuenda A; Eklund KK; Öörni K; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1937-46. PubMed ID: 27417584
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis.
Yalcinkaya M; Liu W; Xiao T; Abramowicz S; Wang R; Wang N; Westerterp M; Tall AR
J Lipid Res; 2024 Apr; 65(4):100534. PubMed ID: 38522750
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus acidophilus K301 Inhibits Atherogenesis via Induction of 24 (S), 25-Epoxycholesterol-Mediated ABCA1 and ABCG1 Production and Cholesterol Efflux in Macrophages.
Hong YF; Kim H; Kim HS; Park WJ; Kim JY; Chung DK
PLoS One; 2016; 11(4):e0154302. PubMed ID: 27120199
[TBL] [Abstract][Full Text] [Related]
19. CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p/LXRα pathway.
Wang G; Chen JJ; Deng WY; Ren K; Yin SH; Yu XH
Cell Death Dis; 2021 Mar; 12(3):254. PubMed ID: 33692340
[TBL] [Abstract][Full Text] [Related]
20. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J
J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
